Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Couvade syndrome equivalent?

Kumar Budur1, Maju Mathews, Manu Mathews

  • 1Department of Psychiatry, Drexel University College of Medicine, Philadelphia, PA 19102, USA.

Psychosomatics
|March 16, 2005
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long-term safety and tolerability of transdermal cannabidiol gel in children and adolescents with Fragile X syndrome (ZYN2-CL-017): an interim analysis of an ongoing open-label extension study.

Journal of neurodevelopmental disorders·2025
Same author

A proof-of-concept study of pitolisant for excessive daytime sleepiness in patients with Prader-Willi syndrome.

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine·2025
Same author

Correction: Pharmacokinetic Characteristics of Long‑Acting Injectable Antipsychotics for Schizophrenia: An Overview.

CNS drugs·2024
Same author

Correction: Continuous Subcutaneous Foslevodopa/Foscarbidopa in Parkinson's Disease: Safety and Efficacy Results From a 12-Month, Single-Arm, Open-Label, Phase 3 Study.

Neurology and therapy·2023
Same author

Continuous Subcutaneous Foslevodopa/Foscarbidopa in Parkinson's Disease: Safety and Efficacy Results From a 12-Month, Single-Arm, Open-Label, Phase 3 Study.

Neurology and therapy·2023
Same author

Esketamine versus placebo on time to remission in major depressive disorder with acute suicidality.

BMC psychiatry·2023
Same journal

Clinical Approach to Personality Change Due to Another Medical Condition.

Psychosomatics·2021
Same journal

Clonazepam for Catatonia Incompletely Responsive to lorazepam.

Psychosomatics·2021
Same journal

Diabetic Retinopathy and Depression: A Risk Assessment.

Psychosomatics·2021
Same journal

WITHDRAWN: Psychosis: A Presentation of COVID-19?

Psychosomatics·2021
Same journal

Dermatitis Neglecta, the Cognitive Assessment, and Micronutrients.

Psychosomatics·2020
Same journal

Coronavirus and Its Implications for Psychiatry: A Rapid Review of the Early Literature.

Psychosomatics·2020
See all related articles